CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 501 enrolled
Drug / intervention
MS-SUPPORTother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04122989
NCT04122989N/ACompleted
CompareCT.gov

Validation of a Shared Decision-Making Tool, MS-SUPPORT, to Improve Decisions About Disease Modifying Therapies (DMT) for Multiple Sclerosis

Shared Decision Making Resources·interventional·Posted Oct 10, 2019·Updated May 9, 2022

In Brief

A clinical study evaluating MS-SUPPORT for Multiple Sclerosis. Completed, enrolled 501 participants across 1 site.

Detailed Summary

This study evaluates a novel shared decision making tool for multiple sclerosis (MS). Half the patients will be given access to MS-SUPPORT before their scheduled appointment with their healthcare provider, the other half will not be given access.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
CountriesUnited States
CollaboratorsEMD Serono, Multiple Sclerosis Association of America

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 10, 2019
Enrollment StartNov 12, 2019
Primary CompletionOct 26, 2020
Study CompletionDec 23, 2021
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 6.7 years ago

Interventions

MS-SUPPORTother

MS-SUPPORT is a shared decision making tool designed to be used by patients and providers.